In vivo mapping of striatal neurodegeneration in Huntington’s disease with Soma and Neurite Density Imaging
Huntington’s disease (HD) is an inherited neurodegenerative disorder characterised by progressive cognitive and motor decline driven by basal ganglia (BG) atrophy. Clinical trials of novel disease-modifying therapies are ongoing, creating a need for sensitive non-invasive imaging biomarkers. Soma and Neurite Density Imaging (SANDI) is a multi-shell diffusion MRI model that estimates intracellular…
We haven't written up this one. eLife has the full story — the link below goes straight to it.
